Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Orkla on its divestment of Enter Fonder to Pareto
Mandate

Vinge advises Orkla on its divestment of Enter Fonder to Pareto

April 04, 2016

Vinge advises Orkla ASA on the divestment (indirectly) of its shares in Enter Fonder to Pareto AS. The transaction makes Pareto the new majority shareholder of Enter. The transaction is subject to relevant approvals from the Swedish Financial Supervisory Authority (Finansinspektionen).

Vinge’s team consists of partner in charge Peter Sundgren (M&A), partner Emma Stuart-Beck (financial regulatory), partner Odile Fallenius and counsel Maria Schultzberg (tax) and associates Oscar Rydén and Louise Nordkvist (M&A).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025